Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation

Blood

Volumn 115, Issue 7, 2010, Pages 1319-1330

  Andronicos, Nicholas M ^a,e   Chen, Emily I ^a,f   Baik, Nagyung ^a   Bai, Hongdong ^a   Parmer, Caitlin M ^a,g   Kiosses, William B ^a   Kamps, Mark P ^b   Yates III, John R ^a   Parmer, Robert J ^c,d   Miles, Lindsey A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e CSIRO   (Australia)

^f STONY BROOK UNIVERSITY   (United States)

^g YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; LYSINE; PLASMINOGEN ACTIVATOR; PLG RKT; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; COLONY STIMULATING FACTOR 1; DETERGENT; HOMEODOMAIN PROTEIN; MESSENGER RNA; PLASMINOGEN; PLG R(KT) PROTEIN, HUMAN; PLG-R(KT) PROTEIN, HUMAN; TRANSCRIPTION FACTOR HOXA9;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; HUMAN; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEOMICS; STEM CELL; UPREGULATION; AMINO ACID SEQUENCE; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR GENETICS; MONOCYTE; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; DETERGENTS; HOMEODOMAIN PROTEINS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MOLECULAR SEQUENCE DATA; MONOCYTES; PLASMINOGEN; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEOMICS; RECEPTORS, CELL SURFACE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RNA, MESSENGER; TISSUE PLASMINOGEN ACTIVATOR; UP-REGULATION;

EID: 77949897126     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-11-188938     Document Type: Article

References (78)

1. Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta. 1985(1):823:35-65.
2. Testa JE, Quigley JP. Protease receptors on cell surfaces: new mechanistic formulas applied to an old problem. J Natl Cancer Inst. 1988;80(10):712-713.
3. Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood. 1998;91(6):2005-2009.
4. Plow EF, Ploplis VA, Busuttil S, Carmeliet P, Collen D. A role of plasminogen in atherosclerosis and restenosis models in mice. Thromb Haemost. 1999;82(suppl 1):4-7.
5. Busuttil SJ, Ploplis VA, Castellino FJ, et al. A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost. 2004;2(10):1798-1805.
6. Das R, Burke T, Plow EF. Histone H2B as a functionally important plasminogen receptor on macrophages. Blood. 2007;110(10):3763-3772.
7. Lund LR, Bjorn SF, Sternlicht MD, et al. Lactational competence and involution of the mouse mammary gland require plasminogen. Development. 2000;127(20):4481-4492.
8. Romer J, Bugge TH, Pyke C, et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med. 1996;2(3):287-292.
9. Creemers E, Cleutjens J, Smits J, et al. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol. 2000;156(6):1865-1873.
10. Ranson M, Andronicos NM, O'Mullane MJ, Baker MS. Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins. Br J Cancer. 1998;77(10):1586-1597.
11. Palumbo JS, Talmage KE, Liu H, et al. Plasminogen supports tumor growth through a fibrinogendependent mechanism linked to vascular patency. Blood. 2003;102(8):2819-2827.
12. Gonzalez-Gronow M, Grenett HE, Gawdi G, Pizzo SV. Angiostatin directly inhibits human prostate tumor cell invasion by blocking plasminogen binding to its cellular receptor, CD26. Exp Cell Res. 2005;303(1):22-31.
13. López-Alemany R, Suelves M, Munoz-Canoves P. Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis. Thromb Haemost. 2003;90(4):724-733.
14. Jiang Q, Taupenot L, Mahata SK, et al. Proteolytic cleavage of chromogranin A (CgA) by plasmin: selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J Biol Chem. 2001;276(27):25022-25029.
15. Jiang Q, Yasothornsrikul S, Taupenot L, Miles LA, Parmer RJ. The local chromaffin cell plasminogen/plasmin system and the regulation of catecholamine secretion. Ann N Y Acad Sci. 2002;971:445-449.
16. Jacovina AT, Zhong F, Khazanova E, et al. Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J Biol Chem. 2001;276(52):49350-49358.
17. Bai H, Dehmelt L, Halpain S, et al. Role of the plasminogen activation system in hippocampal neuritogenesis. J Thromb Haemost. 2006;4(supp 1):146.
18. Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem. 1985;260(7):4303-4311.
19. Stricker RB, Wong D, Tak Shiu D, Reyes PT, Shuman MA. Activation of plasminogen by tissue plasminoagen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. Blood. 1986;68(1):275-280.
20. Hajjar KA, Harpel PC, Jaffe EA, Nachman RL. Binding of plasminogen to cultured human endothelial cells. J Biol Chem. 1986;261(25):11656-11662.
21. Ellis V, Behrendt N, Dano K. Plasminogen activation by receptor-bound urokinase: a kinetic study with both cell-associated and isolated receptor. J Biol Chem. 1991;266(19):12752-12758.
22. Gonias SL, Braud LL, Geary WA, VandenBerg SR. Plasminogen binding to rat hepatocytes in primary culture and to thin slices of rat liver. Blood. 1989;74(2):729-736.
23. Duval-Jobe C, Parmely MJ. Regulation of plasminogen activation by human U937 promonocytic cells. J Biol Chem. 1994;269(33):21353-21357.
24. Félez J, Miles LA, Fabregas P, et al. Characterization of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leukocytic cells. Thromb Haemost. 1996;76(4):577-584.
25. Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and cell surfaces: Evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol. 1986;103(6 pt 1):2411-2420.
26. 2-macroglobulin. J Biol Chem. 1991;266(19):12329-12336.
27. Miles LA, Hawley SB, Baik N, et al. Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Front Biosci. 2005;10:1754-1762.
28. Plow EF, Miles LA. Plasminogen receptors in the mediation of pericellular proteolysis. Cell Differ Dev. 1990;32(2):293-298.
29. Miles LA, Dahlberg CM, Plescia J, et al. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-Enolase as a candidate plasminogen receptor. Biochemistry. 1991;30:1(6)682-1691.
30. Swaisgood CM, Schmitt D, Eaton D, Plow EF. In vivo regulation of plasminogen function by plasma carboxypeptidase B. J Clin Invest. 2002;110(9):1275-1282.
31. Redlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem. 1995;227(1-2):407-415.
32. Hawley SB, Tamura T, Miles LA. Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a. J Biol Chem. 2001;276(1):179-186.
33. Herren T, Burke TA, Das R, Plow EF. Identification of histone H2B as a regulated plasminogen receptor. Biochemistry. 2006;45(31):9463-9474.
34. Falcone DJ, Borth W, Khan KM, Hajjar KA. Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood. 2001;97(3):777-784.
35. Rouhiainen A, Kuja-Panula J, Wilkman E, et al. Regulation of monocyte migration by amphoterin (HMGB1). Blood. 2004;104(4):1174-1182.
36. Fan ZQ, Larson PJ, Bognacki J, et al. Tissue factor regulates plasminogen binding and activation. Blood. 1998;91(6):1987-1998.
37. Pluskota E, Soloviev DA, Bdeir K, Cines DB, Plow EF. Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils. J Biol Chem. 2004;279(17):18063-18072.
38. Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970;170(962):1995-1996.
39. Parmer RJ, Mahata M, Gong Y, et al. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretioin. J Clin Invest. 2000;106(7):907-915.
40. Miles LA, Plow EF. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe. Biochemistry. 1986;25(22):6926-6933.
41. Odegaard JI, Vats D, Zhang L, et al. Quantitative expansion of ES cell-derived myeloid progenitors capable of differentiating into macrophages. J Leukoc Biol. 2007;81(3):711-719.
42. Miles LA, Andronicos NM, Baik N, Parmer RJ. Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells. J Neurosci. 2006;26(50):13017-13024.
43. Hawley SB, Green MA, Miles LA. Discriminating between cell surface and intracellular plasminogen-binding proteins: heterogeneity in profibrinolytic plasminogen-binding proteins on monocytoid cells. Thromb Haemost. 2000;84(5):882-890.
44. Eng JK, McCormick AL, Yates JRI. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom. 1994;5(6):976-989.
45. Link AJ, Eng J, Schieltz DM, et al. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol. 1999;17(7):676-682.
46. Larmann JP Jr, Lemmo AV, Moore AW Jr, Jorgenson JW. Two-dimensional separations of peptides and proteins by comprehensive liquid chromatography-capillary electrophoresis. Electrophoresis. 1993;14(5-6):439-447.
47. Opiteck GJ, Jorgenson JW. Two-dimensional SEC/RPLC coupled to mass spectrometry for the analysis of peptides. Anal Chem. 1997;69(13):2283-2291.
48. Wolters DA, Washburn MP, Yates JR III. An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem. 2001;73(23):5683-5690.
49. Bern M, Goldberg D, McDonald WH, Yates JR III. Automatic quality assessment of peptide tandem mass spectra. Bioinformatics. 2004;20(suppl 1):I49-I54.
50. Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res. 2003;2(1):43-50.
51. European Bioinformatics Institute. International Protein Index (IPI). http://www.ebi.ac.uk/IPI/IPIhelp.html. Accessed December 1, 2006.
52. Yates JR III. Database searching using mass spectrometry data. Electrophoresis. 1998;19(6):893-900.
53. Tabb DL, McDonald WH, Yates JR III. DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J Proteome Res. 2002;1(1):21-26.
54. Pozzi A, Moberg PE, Miles LA, et al. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci U S A. 2000;97(5):2202-2207.
55. Miles LA, Plow EF. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb Haemost. 1987;58(3):936-942.
56. Wang GG, Calvo KR, Pasillas MP, et al. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nat Methods. 2006;3(4):287-293.
57. Collen D, Verstraete M. Molecular biology of human plasminogen, II: metabolism in physiological and some pathophysiological conditions in man. Thromb Diath Haemorrh Suppl. 1975;34(2):403-408.
58. Felez J, Chanquias CJ, Fabregas P, Plow EF, Miles LA. Competition between plasminogen and tissue plasminogen activator for cellular binding sites. Blood. 1993;82(8):2433-2441.
59. National Center for Biotechnology Information. Basic Local Alignment Search Tool (BLAST). http://www.ncbi.nlm.nih.gov/blast/Blast.cgi. Accessed December 1, 2006.
60. Wellcome Trust Sanger. Ensembl. http://www.ensembl.org. Accessed June 11, 2009.
61. National Center for Biotechnology Information. Single Nucleotide Polymorphism. http://www.ncbi.nlm.nih.gov/projects/SNP. Accessed March 8, 2009.
62. Tusnády GE, Simon I. Principles governing amino acid composition of integral membrane proteins: application to topology prediction. J Mol Biol. 1998;283(2):489-506.
63. Lerch-Bader M, Lundin C, Kim H, Nilsson I, von Heijne G. Contribution of positively charged flanking residues to the insertion of transmembrane helices into the endoplasmic reticulum. Proc Natl Acad Sci U S A. 2008;105(11):4127- 4132.
64. SPLIT 4.0 Server. http://split.pmfst.hr/split/4. Accessed March 8, 2009.
65. von Heijne G. Control of topology and mode of assembly of a polytopic membrane protein by positively charged residues. Nature. 1989;341(6241):456-458.
66. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem. 1981;256(4):1604-1607.
67. Estreicher A, Wohlwend A, Belin D, Scleuning W-D, Vassalli JD. Characterization of the cellular binding site for the urokinase-type plasminogen activator. J Biol Chem. 1989;264(2):1180-1189.
68. Bernstein AM, Greenberg RS, Taliana L, Masur SK. Urokinase anchors uPAR to the actin cytoskeleton. Invest Ophthalmol Vis Sci. 2004;45(9):2967-2977.
69. Hajjar KA, Hamel NM, Harpel PC, Nachman RL. Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest. 1987;80(6):1712-1719.
70. Miles LA, Dahlberg CM, Plow EF. The cell-binding domains of plasminogen and their function in plasma. J Biol Chem. 1988;263(24):11928-11934.
71. Felez J, Chanquia CJ, Levin EG, Miles LA, Plow EF. Binding of tissue plasminogen activator to human monocytes and monocytoid cells. Blood. 1991;78(4):2318-2327.
72. Su AI, Cooke MP, Ching KA, et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A. 2002;99(7):4465-4470.
73. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004;101(16):6062- 6067.
74. European Bioinformatics Institute. Array Express Gene Expression ATLAS. http://www.ebi.ac.uk/gxa. Accessed August 19, 2009.
75. Correc P, Fondanèche M-C, Bracke M, Burtin P. The presence of plasmin receptors on three mammary carcinoma MCF-7 sublines. Int J Cancer. 1990;46(4):745-750.
76. Harada JN, Bower KE, Orth AP, et al. Identification of novel mammalian growth regulatory factors by genome-scale quantitative image analysis. Genome Res. 2005;15(8):1136-1144.
77. Nguyen ST, Hasegawa S, Tsuda H, et al. Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma. Cancer Sci. 2007;98(5):740-746.
78. Mitchell JW, Baik N, Castellino FJ, Miles LA. Plasminogen inhibits TNFα-induced apoptosis in monocytes. Blood. 2006;107(11):4383-4390.